<code id='FB26F84C3D'></code><style id='FB26F84C3D'></style>
    • <acronym id='FB26F84C3D'></acronym>
      <center id='FB26F84C3D'><center id='FB26F84C3D'><tfoot id='FB26F84C3D'></tfoot></center><abbr id='FB26F84C3D'><dir id='FB26F84C3D'><tfoot id='FB26F84C3D'></tfoot><noframes id='FB26F84C3D'>

    • <optgroup id='FB26F84C3D'><strike id='FB26F84C3D'><sup id='FB26F84C3D'></sup></strike><code id='FB26F84C3D'></code></optgroup>
        1. <b id='FB26F84C3D'><label id='FB26F84C3D'><select id='FB26F84C3D'><dt id='FB26F84C3D'><span id='FB26F84C3D'></span></dt></select></label></b><u id='FB26F84C3D'></u>
          <i id='FB26F84C3D'><strike id='FB26F84C3D'><tt id='FB26F84C3D'><pre id='FB26F84C3D'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:187

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. 

          How do we ensure the population in a study best reflects the people who will get a medicine in the real world?

          advertisement

          STAT will bring together a panel of leading experts to discuss the best solutions-based approaches.

          Featured speakers:

          • LaShell Robinson,senior director, head of diversity, equity & inclusion in clinical research, Takeda
          • Ramita Tandon, chief clinical trials officer, Walgreens
          • Vindell Washington, M.D., M.S., MS.c, chief clinical officer of care and director of Health Equity Center of Excellence, Verily
          • Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)
          • Jennifer Cullingford, vice president, customer success, OneStudyTeam (sponsor speaker)

          Sponsored By

          OneStudyTeam

           

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Resistance to cancer drugs: A new genetic explanation
          Resistance to cancer drugs: A new genetic explanation

          MetastaticmelanomacellsNCI/NIHCancerdrugscanburnthroughtumorslikeawildfire,killingoffthevastmajority

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          States increasingly look to regulate hospital facility fees

          Hospitalshaveacquiredalotofphysicianofficesandhaveaddedfacilityfeestotheircharges.JEFFPACHOUD/AFPvia